Prime Highlights
- GE HealthCare has received CE Mark approval for its Photonova Spectra photon counting CT scanner, allowing its use across European hospitals.
- The scanner is designed to deliver sharper CT images that could help doctors make more precise diagnoses.
Key Facts
- The approval follows the EU’s medical device regulatory framework.
- GE HealthCare now competes in photon counting CT alongside Siemens Healthineers and Philips.
Background-
GE HealthCare Technologies has secured CE Mark approval for its Photonova Spectra photon counting CT scanner, a move that clears the path for the device to be sold and used across European hospitals and imaging centres.
With this approval in hand, healthcare providers across the region can now bring Photonova Spectra into everyday clinical use under the EU’s medical device rules. The scanner is built to produce sharper, more detailed CT images, which the company says could help doctors spot and diagnose conditions with greater precision.
GE HealthCare, based in the United States, makes imaging equipment and digital health tools used throughout diagnosis, treatment and patient monitoring. Photonova Spectra is the latest piece in the company’s ongoing effort to pair high-end scanners with software that supports clinical decision-making.
Photon counting CT itself is considered a step forward in imaging technology. Rather than measuring X-ray energy the way older scanners do, it counts individual photons, which can translate into clearer images at potentially lower radiation doses for patients.
GE HealthCare now enters this space alongside other established players such as Siemens Healthineers and Philips, both of which already offer their own photon counting systems in Europe.
The approval also ties into GE HealthCare’s larger lineup of advanced imaging projects, including work on radiopharmaceuticals and total body PET scanning, areas the company views as central to its future growth.
The approval also ties into GE HealthCare’s larger lineup of advanced imaging projects, including work on radiopharmaceuticals and total body PET scanning, areas the company views as central to its future growth.
For hospitals weighing their next equipment upgrade, the arrival of Photonova Spectra gives them one more advanced option to consider as they plan investments in next-generation imaging technology.
